|
|
renal system development
|
GO:0072001 |
225 |
0.259
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.222
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.215
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.214
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.189
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.160
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.153
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.148
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.147
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.145
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.144
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.139
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.122
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.120
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.118
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.109
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.108
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.105
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.105
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.095
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.094
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.093
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.091
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.090
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.090
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.089
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.089
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.088
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.088
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.087
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.086
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.086
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.085
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.084
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.083
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.083
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.081
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.081
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.077
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.075
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.075
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.074
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.074
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.073
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.073
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.073
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.072
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.072
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.071
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.068
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.068
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.068
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.066
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.065
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.065
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.062
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.062
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.061
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.060
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.060
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.059
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.058
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.057
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.056
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.055
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.055
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.054
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.054
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.054
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.053
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.053
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.053
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.053
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.052
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.051
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.051
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.051
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.051
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.050
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.049
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.048
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.048
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.048
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.048
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.048
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.046
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.046
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.046
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.046
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.046
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.046
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.046
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.045
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.044
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.044
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.044
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.044
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.044
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.044
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.044
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.044
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.042
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.042
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.042
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.042
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.042
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.042
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.041
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.041
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.041
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.041
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.040
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.040
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.040
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.040
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.039
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.039
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.039
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.039
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.039
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.038
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.038
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.038
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.038
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.038
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.038
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.038
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.037
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.037
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.037
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.037
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.037
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.037
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.036
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.035
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.035
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.035
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.035
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.035
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.035
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.035
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.035
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.034
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.034
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.034
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.034
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.034
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.034
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.033
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.033
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.033
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.033
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.033
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.033
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.033
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.032
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.032
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.032
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.032
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.032
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.032
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.032
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.032
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.032
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.031
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.031
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.031
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.031
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.031
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.031
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.030
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.030
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.030
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.030
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.030
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.030
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.030
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.030
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.029
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.029
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.029
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.029
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.029
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.029
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.029
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.029
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.028
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.028
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.028
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.028
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.028
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.028
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.028
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.028
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.028
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.028
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.028
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.028
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.028
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.027
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.027
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.027
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.027
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.027
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.027
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.026
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.026
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.026
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.026
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.026
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.026
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.026
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.026
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.026
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.026
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.026
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.026
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.025
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.025
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.025
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.025
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.025
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.025
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.025
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.024
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.024
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.024
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.024
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.024
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.024
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.024
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.024
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.024
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.024
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.023
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.023
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.023
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.023
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.023
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.023
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.023
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.023
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.023
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.023
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.023
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.023
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.023
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.023
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.023
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.022
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.022
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.022
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.022
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.022
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.022
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.022
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.022
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.022
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.022
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.022
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.022
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.022
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.021
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.021
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.021
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.021
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.021
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.021
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.021
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.021
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.021
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.021
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.021
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.021
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.021
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.021
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.021
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.021
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.021
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.021
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.021
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.020
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.020
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.020
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.020
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.020
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.020
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.020
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.020
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.020
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.020
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.020
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.020
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.020
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.020
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.020
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.020
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.020
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.019
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.019
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.019
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.019
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.019
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.019
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.019
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.019
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.019
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.019
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.019
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.019
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.018
|
|
|
|
sequestering of bmp in extracellular matrix
|
GO:0035582 |
3 |
0.018
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.018
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.018
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.018
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.018
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.018
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.018
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.018
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.018
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.018
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.018
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.018
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.018
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.017
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.017
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.017
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.017
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.017
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.017
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.017
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.017
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.017
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.017
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.017
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.017
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.017
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.017
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.017
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.017
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.017
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.017
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.017
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.017
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.017
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.017
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.017
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.017
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.017
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.016
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.016
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.016
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.016
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.016
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.016
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.016
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.016
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.016
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.016
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.016
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.016
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.016
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.016
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.016
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.016
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.016
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.016
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.015
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.015
|
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.015
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.015
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.015
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.015
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.015
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.015
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.015
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.015
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.015
|
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.015
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.015
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.015
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.015
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.015
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.015
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.015
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.015
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.015
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.015
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.015
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.015
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.015
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.015
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.015
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.014
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.014
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.014
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.014
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.014
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.014
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.014
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.014
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.014
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.014
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.014
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.014
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.014
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.014
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.014
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.014
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.014
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.014
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.014
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.014
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.014
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.014
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.014
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.014
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.014
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.014
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.014
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.014
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.014
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.014
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.014
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.014
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.014
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.013
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.013
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.013
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.013
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.013
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.013
|
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.013
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.013
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.013
|
|
